Europe Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Pain Management Devices Market would witness market growth of 8.1% CAGR during the forecast period (2020-2026).
The key products used to treat various degrees of pain are electrical stimulators, radiofrequency ablation (RFA), analgesic infusion, and neuromodulation & neurostimulation devices. The market, in 2019 was led by the segment of neuromodulation & neurostimulation devices, which includes spinal cord stimulators (SCS), deep brain stimulators (DBS), and sacral neurostimulators.
These devices have wide-ranging uses in chronic pain management, including spinal cord stimulation, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and electric respiratory stimulation. Neurostimulation devices are more efficient than traditional methods because they show sustained pain reduction. Additionally, traditional therapy requires the intake of medicinal products which may have many adverse effects. Those factors are expected to contribute to this segment 's growth.
Radiofrequency ablation devices played a major role in the treatment of cancer pain. These devices exert action through high-temperature thermal therapy, which by heating tissue to 100°C induces the coagulation of necrotic cells. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
The key products used to treat various degrees of pain are electrical stimulators, radiofrequency ablation (RFA), analgesic infusion, and neuromodulation & neurostimulation devices. The market, in 2019 was led by the segment of neuromodulation & neurostimulation devices, which includes spinal cord stimulators (SCS), deep brain stimulators (DBS), and sacral neurostimulators.
These devices have wide-ranging uses in chronic pain management, including spinal cord stimulation, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and electric respiratory stimulation. Neurostimulation devices are more efficient than traditional methods because they show sustained pain reduction. Additionally, traditional therapy requires the intake of medicinal products which may have many adverse effects. Those factors are expected to contribute to this segment 's growth.
Radiofrequency ablation devices played a major role in the treatment of cancer pain. These devices exert action through high-temperature thermal therapy, which by heating tissue to 100°C induces the coagulation of necrotic cells. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pain Management Devices Market, by Product
1.4.2 Europe Pain Management Devices Market, by Application
1.4.3 Europe Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 Europe Neuromodulation & Neurostimulation Devices Market by Country
4.2 Europe Analgesic Infusion Pumps Market by Country
4.3 Europe Ablation Devices Market by Country
CHAPTER 5. EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 Europe Neuropathic Pain Market by Country
5.2 Europe Musculoskeletal Pain Market by Country
5.3 Europe Cancer Pain Market by Country
5.4 Europe Facial & Migraine Pain Market by Country
5.5 Europe Other Applications Market by Country
CHAPTER 6. EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 Germany Pain Management Devices Market
6.1.1 Germany Pain Management Devices Market by Product
6.1.2 Germany Pain Management Devices Market by Application
6.2 UK Pain Management Devices Market
6.2.1 UK Pain Management Devices Market by Product
6.2.2 UK Pain Management Devices Market by Application
6.3 France Pain Management Devices Market
6.3.1 France Pain Management Devices Market by Product
6.3.2 France Pain Management Devices Market by Application
6.4 Russia Pain Management Devices Market
6.4.1 Russia Pain Management Devices Market by Product
6.4.2 Russia Pain Management Devices Market by Application
6.5 Spain Pain Management Devices Market
6.5.1 Spain Pain Management Devices Market by Product
6.5.2 Spain Pain Management Devices Market by Application
6.6 Italy Pain Management Devices Market
6.6.1 Italy Pain Management Devices Market by Product
6.6.2 Italy Pain Management Devices Market by Application
6.7 Rest of Europe Pain Management Devices Market
6.7.1 Rest of Europe Pain Management Devices Market by Product
6.7.2 Rest of Europe Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pain Management Devices Market, by Product
1.4.2 Europe Pain Management Devices Market, by Application
1.4.3 Europe Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 Europe Neuromodulation & Neurostimulation Devices Market by Country
4.2 Europe Analgesic Infusion Pumps Market by Country
4.3 Europe Ablation Devices Market by Country
CHAPTER 5. EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 Europe Neuropathic Pain Market by Country
5.2 Europe Musculoskeletal Pain Market by Country
5.3 Europe Cancer Pain Market by Country
5.4 Europe Facial & Migraine Pain Market by Country
5.5 Europe Other Applications Market by Country
CHAPTER 6. EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 Germany Pain Management Devices Market
6.1.1 Germany Pain Management Devices Market by Product
6.1.2 Germany Pain Management Devices Market by Application
6.2 UK Pain Management Devices Market
6.2.1 UK Pain Management Devices Market by Product
6.2.2 UK Pain Management Devices Market by Application
6.3 France Pain Management Devices Market
6.3.1 France Pain Management Devices Market by Product
6.3.2 France Pain Management Devices Market by Application
6.4 Russia Pain Management Devices Market
6.4.1 Russia Pain Management Devices Market by Product
6.4.2 Russia Pain Management Devices Market by Application
6.5 Spain Pain Management Devices Market
6.5.1 Spain Pain Management Devices Market by Product
6.5.2 Spain Pain Management Devices Market by Application
6.6 Italy Pain Management Devices Market
6.6.1 Italy Pain Management Devices Market by Product
6.6.2 Italy Pain Management Devices Market by Application
6.7 Rest of Europe Pain Management Devices Market
6.7.1 Rest of Europe Pain Management Devices Market by Product
6.7.2 Rest of Europe Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
LIST OF TABLES
TABLE 1 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 UK PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 UK PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 56 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 57 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 ITALY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 ITALY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 62 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 63 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 64 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 68 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 69 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 70 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 71 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 72 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 73 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 76 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 77 KEY INFORMATION – MEDTRONIC PLC
TABLE 78 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 79 KEY INFORMATION – STRYKER CORPORATION
TABLE 80 KEY INFORMATION – COLFAX CORPORATION
TABLE 1 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 EUROPE CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 EUROPE PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 GERMANY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 GERMANY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 GERMANY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 UK PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 UK PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 UK PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 UK PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 FRANCE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 FRANCE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 FRANCE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 RUSSIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 RUSSIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SPAIN PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 56 SPAIN PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 57 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 SPAIN PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 ITALY PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 ITALY PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 62 ITALY PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 63 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 64 ITALY PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 68 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 69 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 70 REST OF EUROPE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 71 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 72 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 73 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 76 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 77 KEY INFORMATION – MEDTRONIC PLC
TABLE 78 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 79 KEY INFORMATION – STRYKER CORPORATION
TABLE 80 KEY INFORMATION – COLFAX CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
